Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | GNAS complex locus | Starlite/ChEMBL | No references |
Homo sapiens | ATM serine/threonine kinase | Starlite/ChEMBL | No references |
Homo sapiens | huntingtin | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Schistosoma mansoni | GTP-binding protein alpha subunit gna | GNAS complex locus | 394 aa | 450 aa | 28.7 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium ulcerans | carbonic anhydrase | 0.1535 | 0.9609 | 0.9567 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0055 | 0.0139 | 0.0221 |
Loa Loa (eye worm) | eukaryotic-type carbonic anhydrase | 0.1017 | 0.6298 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.007 | 0.0234 | 0.0226 |
Onchocerca volvulus | Huntingtin homolog | 0.0148 | 0.0733 | 0.4696 |
Schistosoma mansoni | tar DNA-binding protein | 0.007 | 0.0234 | 0.0226 |
Brugia malayi | Carbonic anhydrase like protein 2 precursor | 0.0464 | 0.2752 | 0.4363 |
Trypanosoma cruzi | mitochondrial DNA polymerase beta-PAK, putative | 0.0166 | 0.0851 | 0.1208 |
Schistosoma mansoni | tar DNA-binding protein | 0.007 | 0.0234 | 0.0226 |
Schistosoma mansoni | carbonic anhydrase II (carbonate dehydratase II) | 0.1017 | 0.6298 | 0.6295 |
Echinococcus granulosus | tar DNA binding protein | 0.007 | 0.0234 | 0.0372 |
Echinococcus granulosus | carbonic anhydrase | 0.0464 | 0.2752 | 0.437 |
Trypanosoma brucei | mitochondrial DNA polymerase beta | 0.0352 | 0.2036 | 0.3122 |
Schistosoma mansoni | carbonic anhydrase II (carbonate dehydratase II) | 0.1017 | 0.6298 | 0.6295 |
Trypanosoma cruzi | mitochondrial DNA polymerase beta, putative | 0.0352 | 0.2036 | 0.3122 |
Loa Loa (eye worm) | hypothetical protein | 0.0148 | 0.0733 | 0.1152 |
Brugia malayi | Eukaryotic-type carbonic anhydrase family protein | 0.0464 | 0.2752 | 0.4363 |
Mycobacterium leprae | CARBONIC ANHYDRASE (CARBONATE DEHYDRATASE) (CARBONIC DEHYDRATASE) | 0.1596 | 1 | 0.5 |
Echinococcus granulosus | geminin | 0.0197 | 0.1048 | 0.1665 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0055 | 0.0139 | 0.0208 |
Schistosoma mansoni | tar DNA-binding protein | 0.007 | 0.0234 | 0.0226 |
Brugia malayi | Eukaryotic-type carbonic anhydrase family protein | 0.0464 | 0.2752 | 0.4363 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0055 | 0.0139 | 0.0131 |
Plasmodium falciparum | carbonic anhydrase | 0.0464 | 0.2752 | 0.5 |
Schistosoma mansoni | carbonic anhydrase-related | 0.0464 | 0.2752 | 0.2746 |
Mycobacterium tuberculosis | Probable transmembrane carbonic anhydrase (carbonate dehydratase) (carbonic dehydratase) | 0.058 | 0.35 | 0.4758 |
Mycobacterium tuberculosis | Beta-carbonic anhydrase | 0.0955 | 0.5895 | 0.9264 |
Loa Loa (eye worm) | eukaryotic-type carbonic anhydrase | 0.0464 | 0.2752 | 0.4363 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0055 | 0.0139 | 0.0221 |
Brugia malayi | RNA recognition motif domain containing protein | 0.007 | 0.0234 | 0.036 |
Brugia malayi | Eukaryotic-type carbonic anhydrase family protein | 0.0464 | 0.2752 | 0.4363 |
Brugia malayi | TAR-binding protein | 0.007 | 0.0234 | 0.036 |
Trypanosoma brucei | mitochondrial DNA polymerase beta-PAK | 0.0166 | 0.0851 | 0.1208 |
Echinococcus multilocularis | carbonic anhydrase | 0.0464 | 0.2752 | 0.4363 |
Toxoplasma gondii | hypothetical protein | 0.0057 | 0.0149 | 0.0512 |
Schistosoma mansoni | tar DNA-binding protein | 0.007 | 0.0234 | 0.0226 |
Echinococcus granulosus | carbonic anhydrase | 0.0464 | 0.2752 | 0.437 |
Trypanosoma cruzi | carbonic anhydrase-like protein, putative | 0.1017 | 0.6298 | 1 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0055 | 0.0139 | 0.0208 |
Loa Loa (eye worm) | carbonic anhydrase 3 | 0.1017 | 0.6298 | 1 |
Echinococcus granulosus | histone lysine methyltransferase setb | 0.0035 | 0.0008 | 0.0013 |
Loa Loa (eye worm) | hypothetical protein | 0.0148 | 0.0733 | 0.1152 |
Echinococcus multilocularis | carbonic anhydrase | 0.0464 | 0.2752 | 0.4363 |
Schistosoma mansoni | carbonic anhydrase | 0.1596 | 1 | 1 |
Brugia malayi | Eukaryotic-type carbonic anhydrase family protein | 0.1017 | 0.6298 | 1 |
Echinococcus multilocularis | geminin | 0.0197 | 0.1048 | 0.1654 |
Brugia malayi | hypothetical protein | 0.0148 | 0.0733 | 0.1152 |
Leishmania major | carbonic anhydrase family protein, putative | 0.1596 | 1 | 1 |
Loa Loa (eye worm) | RNA binding protein | 0.007 | 0.0234 | 0.036 |
Trypanosoma brucei | carbonic anhydrase-like protein | 0.1017 | 0.6298 | 1 |
Echinococcus granulosus | carbonic anhydrase II | 0.1017 | 0.6298 | 1 |
Brugia malayi | Pre-SET motif family protein | 0.0242 | 0.1337 | 0.2112 |
Leishmania major | carbonic anhydrase-like protein | 0.1017 | 0.6298 | 0.5953 |
Loa Loa (eye worm) | hypothetical protein | 0.0464 | 0.2752 | 0.4363 |
Schistosoma mansoni | carbonic anhydrase-related | 0.0464 | 0.2752 | 0.2746 |
Trichomonas vaginalis | conserved hypothetical protein | 0.1535 | 0.9609 | 1 |
Leishmania major | mitochondrial DNA polymerase beta | 0.0352 | 0.2036 | 0.1296 |
Plasmodium vivax | SET domain protein, putative | 0.0035 | 0.0008 | 0.5 |
Toxoplasma gondii | hypothetical protein | 0.0464 | 0.2752 | 1 |
Loa Loa (eye worm) | TAR-binding protein | 0.007 | 0.0234 | 0.036 |
Echinococcus multilocularis | tar DNA binding protein | 0.007 | 0.0234 | 0.036 |
Onchocerca volvulus | Huntingtin homolog | 0.0148 | 0.0733 | 0.4696 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0055 | 0.0139 | 0.0208 |
Loa Loa (eye worm) | hypothetical protein | 0.0464 | 0.2752 | 0.4363 |
Echinococcus multilocularis | carbonic anhydrase | 0.0464 | 0.2752 | 0.4363 |
Schistosoma mansoni | carbonic anhydrase | 0.0464 | 0.2752 | 0.2746 |
Mycobacterium ulcerans | carbonic anhydrase | 0.1596 | 1 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0464 | 0.2752 | 0.2746 |
Trypanosoma cruzi | mitochondrial DNA polymerase beta-PAK, putative | 0.006 | 0.0171 | 0.0112 |
Mycobacterium tuberculosis | Beta-carbonic anhydrase CanB | 0.1016 | 0.6286 | 1 |
Brugia malayi | RNA binding protein | 0.007 | 0.0234 | 0.036 |
Brugia malayi | Carbonic anhydrase like protein 2 precursor | 0.0464 | 0.2752 | 0.4363 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0055 | 0.0139 | 0.0131 |
Onchocerca volvulus | 0.0276 | 0.1551 | 1 | |
Brugia malayi | Putative carbonic anhydrase 5 precursor | 0.1017 | 0.6298 | 1 |
Echinococcus granulosus | carbonic anhydrase | 0.0464 | 0.2752 | 0.437 |
Trypanosoma cruzi | carbonic anhydrase-like protein, putative | 0.1017 | 0.6298 | 1 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0055 | 0.0139 | 0.0131 |
Echinococcus multilocularis | carbonic anhydrase II | 0.1017 | 0.6298 | 1 |
Loa Loa (eye worm) | pre-SET domain-containing protein family protein | 0.0242 | 0.1337 | 0.2112 |
Trichomonas vaginalis | conserved hypothetical protein | 0.1535 | 0.9609 | 1 |
Schistosoma mansoni | carbonic anhydrase-related | 0.0464 | 0.2752 | 0.2746 |
Schistosoma mansoni | hypothetical protein | 0.0197 | 0.1048 | 0.1041 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0055 | 0.0139 | 0.0208 |
Loa Loa (eye worm) | hypothetical protein | 0.0464 | 0.2752 | 0.4363 |
Trypanosoma cruzi | mitochondrial DNA polymerase beta, putative | 0.0352 | 0.2036 | 0.3122 |
Schistosoma mansoni | hypothetical protein | 0.0197 | 0.1048 | 0.1041 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.007 | 0.0234 | 0.036 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | = 5.6234 um | PUBCHEM_BIOASSAY: qHTS Assay for Identifying a Potential Treatment of Ataxia-Telangiectasia. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 11.2202 uM | PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 17.7828 um | PUBCHEM_BIOASSAY: qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Aggregate Formation (GFP). (Class of assay: confirmatory) [Related pubchem assays: 1482, 1471 ] | ChEMBL. | No reference |
Potency (functional) | = 22.3872 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase). (Class of assay: confirmatory) [Related pubchem assays: 2429 (Confirmation qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase)), 2407 (Probe Development Summary for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase)), 2427 (Thermal Shift Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase))] | ChEMBL. | No reference |
Potency (binding) | = 28.1838 um | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding. (Class of assay: confirmatory) [Related pubchem assays: 596 ] | ChEMBL. | No reference |
Potency (functional) | = 28.1838 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))] | ChEMBL. | No reference |
Potency (functional) | 70.7946 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404] | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.